Michael Yassa

870 total citations
28 papers, 241 citations indexed

About

Michael Yassa is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Cancer Research. According to data from OpenAlex, Michael Yassa has authored 28 papers receiving a total of 241 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 13 papers in Radiation and 10 papers in Cancer Research. Recurrent topics in Michael Yassa's work include Advanced Radiotherapy Techniques (13 papers), Prostate Cancer Treatment and Research (11 papers) and Prostate Cancer Diagnosis and Treatment (10 papers). Michael Yassa is often cited by papers focused on Advanced Radiotherapy Techniques (13 papers), Prostate Cancer Treatment and Research (11 papers) and Prostate Cancer Diagnosis and Treatment (10 papers). Michael Yassa collaborates with scholars based in Canada, France and United States. Michael Yassa's co-authors include David H. Nguyen, Peter Vavassis, Tarek Hijal, B. Fortin, P. Giraud, Nicolas Thiounn, J.M. Bachaud, Houda Bahig, Yann De Rycke and Jean‐Marc Cosset and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and The Journal of Urology.

In The Last Decade

Michael Yassa

28 papers receiving 240 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Yassa Canada 9 110 101 90 54 54 28 241
Chris Mitchell United States 6 191 1.7× 189 1.9× 225 2.5× 92 1.7× 56 1.0× 6 411
Maktav Dinçer Türkiye 12 60 0.5× 99 1.0× 41 0.5× 52 1.0× 47 0.9× 23 329
E. Van Limbergen Belgium 8 98 0.9× 95 0.9× 21 0.2× 28 0.5× 145 2.7× 26 372
Samuel Leung France 7 134 1.2× 93 0.9× 48 0.5× 60 1.1× 68 1.3× 7 377
Arthur Cheung Canada 8 93 0.8× 33 0.3× 50 0.6× 20 0.4× 36 0.7× 13 236
Louis Bazire France 9 85 0.8× 131 1.3× 44 0.5× 71 1.3× 60 1.1× 24 344
John H. Suh United States 7 235 2.1× 26 0.3× 31 0.3× 32 0.6× 34 0.6× 9 326
Thomas Hendrik Knocke Austria 9 59 0.5× 118 1.2× 37 0.4× 12 0.2× 44 0.8× 12 364
C. Giordano Italy 12 113 1.0× 147 1.5× 171 1.9× 36 0.7× 174 3.2× 21 369
Valentina Vanoni Italy 12 97 0.9× 104 1.0× 131 1.5× 42 0.8× 100 1.9× 21 332

Countries citing papers authored by Michael Yassa

Since Specialization
Citations

This map shows the geographic impact of Michael Yassa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Yassa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Yassa more than expected).

Fields of papers citing papers by Michael Yassa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Yassa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Yassa. The network helps show where Michael Yassa may publish in the future.

Co-authorship network of co-authors of Michael Yassa

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Yassa. A scholar is included among the top collaborators of Michael Yassa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Yassa. Michael Yassa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Niazi, Tamim, Abdenour Nabid, Talía Malagón, et al.. (2024). Hypofractionated Dose Escalation Radiotherapy for High-Risk Prostate Cancer: the survival analysis of the Prostate Cancer Study-5 (PCS-5), a GROUQ-led phase III trial. European Urology. 87(3). 314–323. 3 indexed citations
2.
Sidéris, Lucas, et al.. (2024). Concurrent Olaparib and Radiation Therapy for BRCA2-Mutated Breast Cancer. Advances in Radiation Oncology. 9(7). 101528–101528. 2 indexed citations
3.
Kim, Do‐Hoon, Valérie Théberge, Sameer Parpia, et al.. (2024). OPAR: A Randomized Trial of Partial Breast Irradiation in Five Fractions Once Daily for Early Breast Cancer. Journal of Clinical Oncology. 43(5). 505–512. 1 indexed citations
4.
Niazi, Tamim, Abdenour Nabid, Talía Malagón, et al.. (2023). Hypofractionated, Dose Escalation Radiation Therapy for High-Risk Prostate Cancer: The Safety Analysis of the Prostate Cancer Study-5, a Groupe de Radio-Oncologie Génito-Urinaire de Quebec Led Phase 3 Trial. International Journal of Radiation Oncology*Biology*Physics. 118(1). 52–62. 9 indexed citations
5.
Cao, Jeffrey, et al.. (2023). Safety of CDK4/6 Inhibitors Combined with Radiotherapy in Patients with Metastatic Breast Cancer: A Review of the Literature. Current Oncology. 30(6). 5485–5496. 5 indexed citations
6.
Tsui, James Man Git, Michael Jonathan Kucharczyk, Abdenour Nabid, et al.. (2021). The Clinical Significance of Bone Mineral Density Changes Following Long-Term Androgen Deprivation Therapy in Localized Prostate Cancer Patients. The Journal of Urology. 205(6). 1648–1654. 4 indexed citations
7.
Vavassis, Peter, David H. Nguyen, Marie‐Christine Guilbert, et al.. (2020). Tumour Response 3 Months after Neoadjuvant Single-Fraction Radiotherapy for Low-Risk Breast Cancer. Current Oncology. 27(3). 155–158. 8 indexed citations
8.
Bedwani, Stéphane, et al.. (2020). Cardiac Sparing with Personalized Treatment Planning for Early-stage Left Breast Cancer. Cureus. 12(3). e7247–e7247. 8 indexed citations
9.
Fortin, B., et al.. (2019). Are radiation oncologists following guidelines? An audit of practice in patients with uncomplicated bone metastases. Technical Innovations & Patient Support in Radiation Oncology. 9. 13–17. 2 indexed citations
10.
Vavassis, Peter, et al.. (2017). Hypofractionation for prostate cancer: an update. Expert Review of Endocrinology & Metabolism. 12(3). 199–205. 1 indexed citations
11.
Moran, Meena S., Yinjun Zhao, Shuangge Ma, et al.. (2017). Association of Radiotherapy Boost for Ductal Carcinoma In Situ With Local Control After Whole-Breast Radiotherapy. JAMA Oncology. 3(8). 1060–1060. 48 indexed citations
12.
Hijal, Tarek, et al.. (2015). Radiothérapie externe hypofractionnée du cancer du sein localisé : où en est-on ?. Cancer/Radiothérapie. 19(6-7). 426–430. 1 indexed citations
13.
14.
Hathout, Lara, Tarek Hijal, Valérie Théberge, et al.. (2013). Hypofractionated Radiation Therapy for Breast Ductal Carcinoma In Situ. International Journal of Radiation Oncology*Biology*Physics. 87(5). 1058–1063. 29 indexed citations
15.
Vavassis, Peter, David H. Nguyen, Jean-Paul Bahary, & Michael Yassa. (2012). Hypofractionated radiotherapy in prostate cancer. Expert Review of Anticancer Therapy. 12(7). 965–972. 3 indexed citations
16.
Giraud, P., Guy Kantor, Michael Yassa, et al.. (2011). Two-Year Clinical Experience With Tomotherapy: The French National Cancer Institute Project on Implementing New Technology. Cancer Investigation. 29(8). 557–563. 6 indexed citations
17.
Mahé, Marc-André, A. Lisbona, S. Zefkili, et al.. (2011). Mesothelioma at era of helical tomotherapy: Results of two institutions in combining chemotherapy, surgery and radiotherapy. Lung Cancer. 74(3). 486–491. 11 indexed citations
18.
Yassa, Michael, Yann De Rycke, J.M. Bachaud, et al.. (2011). Male pattern baldness and the risk of prostate cancer. Annals of Oncology. 22(8). 1824–1827. 34 indexed citations
19.
Dejean, C., G. Kantor, A. Lisbona, et al.. (2010). Tomothérapie hélicoïdale : aspects techniques et applications cliniques. Bulletin du Cancer. 97(7). 783–789. 8 indexed citations
20.
Yassa, Michael, B. Fortin, Marie-Andrée Fortin, et al.. (2008). Combined Hypofractionated Radiation and Hormone Therapy for the Treatment of Intermediate-Risk Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 71(1). 58–63. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chris Mitchell Breakdown of academic impact, for papers by Maktav Dinçer Breakdown of academic impact, for papers by E. Van Limbergen Breakdown of academic impact, for papers by Samuel Leung Breakdown of academic impact, for papers by Arthur Cheung Breakdown of academic impact, for papers by Louis Bazire Breakdown of academic impact, for papers by John H. Suh Breakdown of academic impact, for papers by Thomas Hendrik Knocke Breakdown of academic impact, for papers by C. Giordano Breakdown of academic impact, for papers by Valentina Vanoni
Rankless by CCL
2026